-
Thematic Analysis
New![]()
Music, Film, and TV Sector Scorecard, Q3 2023 Update – Thematic Intelligence
Since the last quarter, Tencent has jumped from ninth to second position on the thematic screen of GlobalData’s music, film, and TV sector scorecard. The high ranking is due to its strength in themes like video streaming, ecommerce, and social media. While Tencent is on the rise, Apple has slipped one position to fourth despite its score for the internet advertising theme increasing to 5 out of 5 from 4 out of 5. Apple’s advertising revenue is growing steadily, challenging...
-
Company Insights
New![]()
Business of UEFA Club Competitions 2023-24 – Property Profile, Sponsorship and Media Landscape
Business of UEFA Club Competitions 2023-2024 Report Overview In 2023, the estimated sponsorship revenue of the UEFA Champions League is $606.33 million, and the UEFA Europa League and Europa Conference League is valued at $314 million. All three UEFA competitions have developed a strong social media presence and TV broadcasters continue to cover UEFA’s three club competitions. The Champions League is the most followed soccer competition in the world on social media. Business of the UEFA Club Competitions 2023-2024 research...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Irinotecan Hydrochloride in Medulloblastoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Irinotecan Hydrochloride in MedulloblastomaDrug Details:irinotecan hydrochloride is under development for the treatment of recurrent pediatric solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Irinotecan Hydrochloride in Hepatic (Liver) Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Irinotecan Hydrochloride in Hepatic (Liver) TumorDrug Details:irinotecan hydrochloride is under development for the treatment of recurrent pediatric...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Miricorilant in Alcohol Addiction
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Miricorilant in Alcohol Addiction Drug Details: Miricorilant (CORT-118335) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Donafenib Tosylate in Pancreatic Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Donafenib Tosylate in Pancreatic Cancer Drug Details: Donafenib tosylate (Zepsun) is a deuterated sorafenib derivative....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Abexinostat in Diffuse Large B-Cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Abexinostat in Diffuse Large B-Cell Lymphoma Drug Details: Abexinostat (PCI-24781) is under development for the...
-
Thematic Analysis
New![]()
Social Media – Thematic Intelligence
Social Media Report Overview Social media companies are diversifying away from their ad-funded business model due to increased regulatory scrutiny. In 2023 alone, some leading players have been fined for breaching data privacy laws over their ad-targeting practices. Regulators have also accused them of monopolistic behavior around access to personal data. The social media thematic report provides an overview of the social media theme. It identifies the key trends impacting the growth of the sector over the next 12 to...
-
Product Insights
![]()
AMC Dev – AMC Park – South Dade Apartment Complex – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our AMC Dev - AMC Park - South Dade Apartment Complex - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Avelumab in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Avelumab in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Drug...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.